✦ LIBER ✦

60 SILEN-C1: SUSTAINED VIROLOGIC RESPONSE (SVR) AND SAFETY OF BI201335 COMBINED WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN (P/R) IN TREATMENT-NAIVE PATIENTS WITH CHRONIC GENOTYPE 1 HCV INFECTION

✍ Scribed by M.S. Sulkowski; E. Ceasu; T. Asselah; F.A. Caruntu; J. Lalezari; P. Ferenci; A. Streinu-Cercel; H. Fainboim; H. Tanno; L. Preotescu; B. Leggett; F. Bessone; S. Mauss; J.O. Stern; C. Häfner; Y. Datsenko; G. Nehmiz; W. Böcher; G. Steinmann

Book ID: 117379206
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 42 KB
Volume: 54
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(11)60062-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

66 SILEN-C2: SUSTAINED VIROLOGIC RESPONS

66 SILEN-C2: SUSTAINED VIROLOGIC RESPONSE (SVR) AND SAFETY OF BI201335 COMBINED WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN (P/R) IN CHRONIC HCV GENOTYPE-1 PATIENTS WITH NON-RESPONSE TO P/R

✍ M.S. Sulkowski; M. Bourliere; J.-P. Bronowicki; A. Streinu-Cercel; L. Preotescu; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 41 KB

1190 SILEN-C2: EARLY ANTIVIRAL ACTIVITY

1190 SILEN-C2: EARLY ANTIVIRAL ACTIVITY AND SAFETY OF BI 201335 COMBINED WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN (PEGIFN/RBV) IN CHRONIC HCV GENOTYPE-1 PATIENTS WITH NON-RESPONSE TO PEGIFN/RBV

✍ Sulkowski, M.; Bourliere, M.; Bronowicki, J.-P.; Streinu-Cercel, A.; Preotescu, 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 68 KB

522 Combination therapy with peginterfer

522 Combination therapy with peginterferon alfa-2A (40KD) (PEGASYS®) plus ribavirin (COPEGUS®) in treatment-naive patients with chronic hepatitis C and genotype 1 infection: Individual estimated probability of sustained virological response (SVR)

✍ O. Weiland; M.W. Fried; S.J. Hadziyannis; G.R. Foster; D. Messinger; K. Freivoge 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 62 KB

290 EARLY VIROLOGICAL RESPONSE PROFILES

290 EARLY VIROLOGICAL RESPONSE PROFILES WITH TELAPREVIR (T) IN COMBINATION WITH PEGINTERFERON-ALFA-2A (P) AND RIBAVIRIN (R) IN GENOTYPE 1 HCV TREATMENT-NAIVE AND TREATMENT-EXPERIENCED PATIENTS ARE SIMILAR

✍ F. Poordad; J.G. McHutchison; M.L. Shiffman; T. Berg; A.J. Muir; M.P. Manns; A.M 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 188 KB

Faldaprevir combined with pegylated inte

Faldaprevir combined with pegylated interferon alfa-2a and ribavirin in treatment-naïve patients with chronic genotype1 HCV: SILEN-C1 trial

✍ Sulkowski, Mark S.; Asselah, Tarik; Lalezari, Jacob; Ferenci, Peter; Fainboim, H 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 756 KB

101 SVR4 AND SVR12 WITH AN INTERFERON-FR

101 SVR4 AND SVR12 WITH AN INTERFERON-FREE REGIMEN OF BI201335 AND BI207127, +/- RIBAVIRIN, IN TREATMENT-NAIVE PATIENTS WITH CHRONIC GENOTYPE-1 HCV INFECTION: INTERIM RESULTS OF SOUND-C2

✍ S. Zeuzem; V. Soriano; T. Asselah; J.-P. Bronowicki; A. Lohse; B. Müllhaupt; M. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 158 KB